Orthovanadate, an inhibitor of protein tyrosine phosphatases, acts more potently as a promoter than as an initiator in the BALB/3T3 cell transformation

Carcinogenesis

Volumn 18, Issue 7, 1997, Pages 1395-1399

  Sakai, Ayako ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; ORTHOVANADIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STRAIN 3T3; CELL TRANSFORMATION; DEPHOSPHORYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR PROMOTION;

3T3 CELLS; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; ENZYME INHIBITORS; MICE; PROTEIN-TYROSINE-PHOSPHATASE; VANADATES;

EID: 0031419427     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.7.1395     Document Type: Article

References (59)

1. Niedel, J.E., Kuhn, L.J. and Vandenbark, G.R. (1983) Phorbol diester receptor copurifies with protein kinase C. Proc. Natl Acad. Sci. USA, 80, 36-40.
2. Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U. and Nishizuka, Y. (1982) Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem., 257, 7847-7851.
3. Nishizuka, Y. (1984) The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature (Lond.), 308, 693-698.
4. Bialojan, C. and Takai, A. (1988) Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases: specificity and kinetics. Biochem. J., 256, 283-290.
5. Haystead, T.A.J., Sim, A.T.R., Carling, D., Honnor, R.C., Tsukitani, Y., Cohen, P. and Hardie, D.G. (1989) Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism. Nature (Lond.), 337, 78-81.
6. Cohen, P., Holmes, C.F.B. and Tsukitani, Y. (1990) Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem. Sci., 15, 98-102.
7. Cohen, P. (1989) The structure and regulation of protein phosphatases. Annu. Rev. Biochem., 58, 453-508.
8. Zhao, Z., Shen, S.-H. and Fischer, E.H. (1994) Phorbol ester-induced expression, phosphorylation, and translocation of protein-tyrosinephosphatase 1C in HL-60 cells. Proc. Natl Acad. Sci. USA, 91, 5007-5011.
9. Issinger, O.-G., Martin, J., Richter, W.W., Olson, M. and Fujiki, H. (1988) Hyperphosphorylation of N-60, a protein structurally and immunologically related to nucleolin after tumour-promoter treatment. EMBO J., 7, 1621-1626.
10. Guy, G.R., Gao, X., Chua, S.P. and Tan, Y.H. (1992) Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1. J. Biol. Chem., 267, 1846-1852.
11. Gilmore, T. and Martin, G.S. (1983) Phorbol ester and diacylglycerol induce protein phosphorylation at tyrosine. Nature (Lond.), 306, 487-490.
12. Nel, A.E., Navailles, M., Rosberger, D.F., Landreth, G.E., Goldschmidt-Clermont, P.J., Baldwin, G.J. and Galbraith, R.M. (1985) Phorbol ester induces tyrosine phosphorylation in normal and abnormal human B lymphocytes. J. Immunol., 135, 3448-3453.
13. Force, T., Kyriakis, J.M., Avruch, J. and Bonventre, J.V. (1991) Endothelin, vasopressin, and angiotensin II enhance tyrosine phosphorylation by protein kinase C-dependent and -independent pathways in glomerular mesangial cells. J. Biol. Chem., 266, 6650-6656.
14. Witte, O.N. (1986) Functions of the abl oncogene. Cancer Surv., 5, 183-197.
15. Brickell, P.M. (1992) the p60c-src family of protein-tyrosine kinases: structure, regulation, and function. Crit. Rev. Oncog., 3, 401-446.
16. Brautigan, D.L. and Shriner, C.L. (1988) Methods to distinguish various types of protein phosphatase activity. Methods Enzymol., 159, 339-346.
17. William Lau, K.-H., Farley, J.R. and Baylink, D.J. (1989) Phosphotyrosyl protein phosphatases. Biochem. J., 257, 23-36.
18. Fischer, E.H., Charbonneau, H. and Tonks, N.K. (1991) Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science, 253, 401-106.
19. Walton, K.M. and Dixon, J.E. (1993) Protein tyrosine phosphatases. Annu. Rev. Biochem., 62, 101-120.
20. Swarup, G., Cohen, S. and Garbers, D.L. (1982) Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem. Biophys. Res. Commun., 107, 1104-1109.
21. Gordon, J.A. (1991) Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol., 201, 477-482.
22. v-src kinase activity by vanadate in intact cells accompanies a new phosphorylation state of the enzyme. J. Biol. Chem., 259, 9580-9586.
23. Klarlund, J.K. (1985) Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins. Cell, 41, 707-717.
24. Carpenter, G. (1981) Vanadate, epidermal growth factor and the stimulation of DNA synthesis. Biochem. Biophys. Res. Commun., 102, 1115-1121.
25. 1 arrest in quiescent and senescent cells treated with phosphatase inhibitors. Cancer Res., 54, 2317-2321.
26. Smets, L.A. (1980) Cell transformation as a model for tumor induction and neoplastic growth. Biochim. Biophys. Acta, 605, 93-111.
27. Barrett, J.C., Kakunaga, T., Kuroki, T., Neubert, D., Trosko, J.E., Vasiliev, J.M., Williams, G.M. and Yamasaki, H. (1986) Mammalian cell transformation in culture. In Montesano, R., Bartsch, H., Vainio, H., Wilbourn, J. and Yamasaki, H. (eds), Long-term and Short-term Assays for Carcinogenesis: A Critical Appraisal. IARC Scientific Publication no. 83, IARC, Lyons, France, pp. 267-286.
28. Mondal, S. and Heidelberger, C. (1976) Transformation of C3H/10T1/2 C18 mouse embryo fibroblasts by ultraviolet irradiation and a phorbol ester. Nature (Lond.), 260, 710-711.
29. Kuroki, T. and Sasaki, K. (1985) Relationship between in vitro cell transformation and in vivo carcinogenesis based on available data on the effects of chemicals. In Kakunaga, T. and Yamasaki, H. (eds), Transformation Assay of Established Cell Lines: Mechanisms and Application. IARC Scientific Publication no. 67, IARC, Lyons, France, pp. 93-118.
30. Katoh, F., Fitzgerald, D.J., Giroldi, L., Fujiki, H., Sugimura, T. and Yamasaki, H. (1990) Okadaic acid and phorbol esters: comparative effects of these tumor promoters on cell transformation, intercellular communication and differentiation in vitro. Japan. J. Cancer Res., 81, 590-597.
31. Sakai, A. and Fujiki, H. (1991) Promotion of BALB/3T3 cell transformation by the okadaic acid class of tumor promoters, okadaic acid and dinophysistoxin-1. Japan. J. Cancer Res., 82, 518-523.
32. Sakai, A., Umeda, M., Nakamura, Y., Sasaki, K. and Iwase, Y. (1993) In vitro assays for tumor promoters. Environ. Mut. Res. Commun., 15, 131-153.
33. Ullrich, A., Coussens, L., Hayflick, J.S. et al. (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (Lond.), 309, 418-425.
34. Williams, L.T. (1989) Signal transduction by the platelet-derived growth factor receptor. Science, 243, 1564-1570.
35. Ullrich, A. and Schlessinger, J. (1990) Signal transduction by receptors with tyrosine kinase activity. Cell, 61, 203-212.
36. Fisher, P.B., Mufson, R.A., Weinstein, I.B. and Little, J.B. (1981) Epidermal growth factor, like tumor promoters, enhances viral and radiation-induced cell transformation. Carcinogenesis, 2, 183-187.
37. Arima, T., Tada, S., Makita, Y., Kurono, M. and Umeda, M. (1995) Effect of Clostridium perfringens derived wound healing substance as compared with epidermal growth factor on the growth and morphological transformation of BALB/3T3 A31-1-1 cells. Mutat. Res., 341, 217-224.
38. Mordan, L.J. (1988) Induction by growth factors from platelets of the focus-forming transformed phenotype in carcinogen-treated C3H/10T1/2 fibroblasts. Carcinogenesis, 9, 1129-1134.
39. Kowalski, L.A., Tsang, S.-S. and Davison, A.J. (1992) Vanadate enhances transformation of bovine papillomavirus DNA-transfected C3H/10T1/2 cells. Cancer Lett., 64, 83-90.
40. Rivedal, E., Roseng, L.E. and Sanner, T. (1990) Vanadium compounds promote the induction of morphological transformation of hamster embryo cells with no effect on gap junctional cell communication. Cell Biol. Toxicol., 6, 303-314.
41. Afshari, C.A., Kodama, S., Bivins, H.M. Willard, T.B., Fujiki, H. and Barrett, J.C. (1993) Induction of neoplastic progression in Syrian hamster embryo cells treated with protein phosphatases inhibitors. Cancer Res., 53, 1777-1782.
42. IARC/NCI/EPA Working Group (1985) Cellular and molecular mechanisms of cell transformation and standardization of transformation assays of established cell lines for the prediction of carcinogenic chemicals: overview and recommended protocols. Cancer Res., 45, 2395-2399.
43. Sheu, C.W., Rodriguez, I. and Lee, J.K. (1992) Proliferation and morphological transformation of BALB/3T3 cells by prolonged treatment with sodium orthovanadate. Food Chem. Toxicol., 30, 307-311.
44. Sabbioni, E., Pozzi, G., Pintar, A., Casella, L. and Garattini, S. (1991) Cellular retention, cytotoxicity and morphological transformation by vanadium (VI) and vanadium (V) in BALB/3T3 cell lines. Carcinogenesis, 12, 47-52.
45. Parfett, C.L.J. and Pilon, R. (1995) Oxidative stress-regulated gene expression and promotion of morphological transformation induced in C3H/10T1/2 cells by ammonium metavanadate. Food Chem. Toxicol., 33, 301-308.
46. Sakai, A., Miyata, N. and Takahashi, A. (1995) Initiating activity of quinones in the two-stage transformation of BALB/3T3 cells. Carcinogenesis, 16, 477-481.
47. Sakai, A. and Sato, M. (1989) Improvement of carcinogen identification in BALB/3T3 cell transformation by application of a two-stage method. Mutat. Res., 214, 285-296.
48. Berenblum, I. (1941) The cocarcinogenic action of croton resin. Cancer Res., 1, 44-48.
49. Berenblum, I. (1941) The mechanism of carcinogenesis: a study of the significance of cocarcinogenic action and related phenomena. Cancer Res., 1, 807-814.
50. Sheu, C.W., Moreland, F.M. and Dunkel, V.C. (1987) The effect of cell passage on the susceptibility of BALB/3T3 clone A31-1-1 cells to 3-methylcholanthrene-induced morphological transformation. Environ. Mutagen., 9, 59-67.
51. Migliore, L., Bocciardi, R., Macrì, C. and Lo Jacono, F. (1993) Cytogenetic damage induced in human lymphocytes by four vanadium compounds and micronucleus analysis by fluorescence in situ hybridization with a centromeric probe. Mutat. Res., 319, 205-213.
52. Paton, G.R. and Allison, A.C. (1972) Chromosome damage in human cell cultures induced by metal salts. Mutat. Res., 16, 332-336.
53. Ciranni, R., Antonetti, M. and Migliore, L. (1995) Vanadium salts induce cytogenetic effects in in vivo treated mice. Mutat. Res., 343, 53-60.
54. Yamasaki, H., Ashby, J., Bignami, M. et al. (1996) Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project. Mutat. Res., 353, 47-63.
55. Cohen, S.M. and Ellwein, L.B. (1990) Cell proliferation in carcinogenesis. Science, 249, 1007-1011.
56. Melnick, R.L., Huff, J., Barrett, J.C., Maronpot, R.R., Lucier, G. and Portier, C.J. (1993) Cell proliferation and chemical carcinogenesis: symposium overview. Environ. Health Perspect., 101 (Suppl. 5), 3-8.
57. Colburn, N.H., Wendel, E.J. and Abruzzo, G. (1981) Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: mitogen-resistant variants are sensitive to promotion. Proc. Natl Acad. Sci. USA, 78, 6912-6916.
58. Hirakawa, T., Kakunaga, T., Fujiki, H. and Sugimura, T. (1982) A new tumor-promoting agent, dihydroteleocidin B, markedly enhances chemically induced malignant cell transformation. Science, 216, 527-529.
59. Sakai, A., Miyata, N. and Takahashi, N. (1997) Promoting activity of 3-tert-butyl-4-hydroxyanisole (BHA) in BALB/3T3 cell transformation. Cancer Lett., in press.